🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to determine the safety and activity ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2010-02
Trial ID
NCT01068769
Treatments Being Tested
Combination of anti-angiogenic molecular targeted therapy and anti- program...
Status
Unknown
Location
National Taiwan University Hospital
Start Date
2020-12-16
Trial ID
NCT04183088
This phase II trial studies how well regorafenib and gemcitabine hydrochlor...
Status
Terminated
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2016-06-14
Trial ID
NCT02383433
Treatments Being Tested
The main purpose of this study is to test the safety, tolerable side effect...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2018-10-23
Trial ID
NCT03712943
Treatments Being Tested
The purpose of this study is to see whether a drug called regorafenib might...
Status
Completed
Location
Sarcoma Oncology Center
Start Date
2014-06-13
Trial ID
NCT02048722
Treatments Being Tested
The investigators hypothesize that patients with mCRC RAS-mutant eligible f...
Status
Recruiting
Location
Istituto Nazionale Tumori | "Fondazione Pascale"
Start Date
2025-10-16
Trial ID
NCT07213570
Treatments Being Tested
A prospective, multicenter, randomized in a 2:1 ratio, controlled, clinical...
Status
Unknown
Location
Chung-Ho Memorial Hospital, Kaohsiung Medical University:
Start Date
2019-02-26
Trial ID
NCT03880877
This is a phase I/II study of the combination of Guadecitabine (SGI-110) an...
Status
Completed
Location
USC / Norris Comprehensive Cancer Center
Start Date
2013-10-23
Trial ID
NCT01896856
Treatments Being Tested
Colorectal cancer is one of the most common malignancies in China. Regorafe...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2019-03-12
Trial ID
NCT03946917
Treatments Being Tested
The primary objective of this study is to define the pharmacokinetic of Reg...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02398513
Treatments Being Tested